Stay updated on Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.3%
    Check dated 2025-01-12T17:20:32.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-01-05T14:00:21.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.2%
    Check dated 2024-12-14T22:33:19.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.
    Difference
    2%
    Check dated 2024-12-07T14:08:43.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Several key resources related to lymphoma and clinical trials have been removed, including links to MedlinePlus and PubMed articles, which may impact access to important medical information.
    Difference
    4%
    Check dated 2024-11-23T04:26:51.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, with numerous new resources added related to lymphoma and clinical trials, while the previous version 2.12.1 has been removed.
    Difference
    4%
    Check dated 2024-11-15T23:12:46.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.